Viewing data from:

BETHANECHOL CHLORIDE

ANDA

BETHANECHOL CHLORIDE | A040483 | ABLE LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Bethanechol Chloride (2023)

Total Spending

$12.0M

Total Claims

192,129

Beneficiaries

44,613

Avg Cost/Unit

$0.57

Spending Trend

$14.9M(2019)→$16.7M(2020)→$15.1M(2021)→$13.1M(2022)→$12.0M(2023)

YoY Change:-6.8%

5yr CAGR:-5.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED EVIONNAZ SABETHANECHOL CHLORIDE

DMF 157372001

SERATEC SASBETHANECHOL CHLORIDE USP

DMF 158662002

WOCKHARDT LTDBETHANECHOL CHLORIDE USP

DMF 161192002

GANES CHEMICALS INC PENNSVILLE DIVInactiveBETHANECHOL CHLORIDE

DMF 25011975

GANES CHEMICALS INC PENNSVILLE DIVInactiveBETHANECHOL CHLORIDE

DMF 43481981

CK FINE CHEMICALS INCInactiveBETHANECHOL CHLORIDE

DMF 47661982

CORDEN PHARMA BERGAMO SPAInactiveBETHANECHOL CHLORIDE

DMF 152132000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 27, 2004

No patent or exclusivity listings for this strength.